EARLY CRT MONITORING USING TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY DOES NOT ADD TO VISUAL ACUITY FOR PREDICTING VISUAL LOSS IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL RANIBIZUMAB-Reference-Cited by-同舟云学术

EARLY CRT MONITORING USING TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY DOES NOT ADD TO VISUAL ACUITY FOR PREDICTING VISUAL LOSS IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL RANIBIZUMAB

Published:2017-03 Issue:3 Volume:37 Page:509-514
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Bell Katy J. L.,Hayen Andrew,Glasziou Paul,Mitchell Andrew S.,Farris Maria,Wright Jonathan,Duerr Hans-Peter,Mitchell Paul,Irwig Les

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference17 articles.

1. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study;Brown;Ophthalmology,2010

2. Reading speed improvements in retinal vein occlusion after ranibizumab treatment;Suner;JAMA Ophthalmol,2013

3. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials;Varma;Ophthalmology,2012

4. Clinical applications and new developments of optical coherence tomography: an evidence-based review;Chen;Clin Exp Optom,2007

5. Criteria for monitoring tests were described: validity, responsiveness, detectability of long-term change, and practicality;Bell;J Clin Epidemiol,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-Week Central Macular Thickness Reduction Rate >37% Predicts the Long-Term Efficacy of Anti-vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion;Frontiers in Medicine;2022-03-07

2. Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab;BMC Ophthalmology;2018-02-09